Rechallenge and maintenance therapy using cetuximab and chemotherapy administered to a patient with metastatic colorectal cancer

BACKGROUND: Cetuximab combined with chemotherapy is one of the first-line treatments of metastatic colorectal cancer. Although disease progression inevitably occurs, rechallenge and maintenance therapies using cetuximab-based regimens may be beneficial, particularly for patients with wild-type (WT)...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Jian, Yang, Quan-liang, Ling, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5310018/
https://www.ncbi.nlm.nih.gov/pubmed/28196490
http://dx.doi.org/10.1186/s12885-017-3133-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5310018/
https://www.ncbi.nlm.nih.gov/pubmed/28196490
http://dx.doi.org/10.1186/s12885-017-3133-8

Ejemplares similares